Revisiting the Incidence of Hypercalcemia in Contemporary Diagnoses of Pediatric Patients With Solid Tumors
This work describes the largest retrospective series of pediatric patients with solid tumors and hypercalcemia to date. Hypercalcemia was most frequently reported for a small subset of diseases, suggesting that disease histology, biology, and the intensive therapeutic interventions required to treat these diseases may be contributing to hypercalcemic risk.
Authors
- Wendy B. London (ORCID: https://orcid.org/0000-0003-3571-6538)
- Allison F. O’Neill (ORCID: https://orcid.org/0000-0002-8957-3870)
- Felicia Ho (ORCID: https://orcid.org/0000-0002-1750-5721)
- Chalinee Monsereenusorn (ORCID: https://orcid.org/0000-0001-7960-5667)
- Nan Chen (ORCID: https://orcid.org/0009-0007-4593-0972)
- Dajana Alku
Institutions
- Harvard University (US)
- Long Island University (US)
- Phramongkutklao Hospital (TH)
- Dana-Farber Cancer Institute (US)
- New York University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1002/pbc.32044
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.05